Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple ...

Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...

Despite a decline in total revenue, Schrodinger Inc (SDGR) strengthens its financial position with a major Novartis ...

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on SDGR stock, giving a Buy rating yesterday. Mani Foroohar has ...

A Holiday Craft Fair will be held from 8:30 a.m. to 3 p.m. Saturday, Nov. 16, at the Gregg Park Civic Center, 1001 A Ave., ...

THE Washington Consensus is in my view was something of a Schrodinger's Cat. Alive when the West were telling others to ...

Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.86 per share a year ago. These figures ...

Imparting domain knowledge like this, however, does carry some less-appealing characteristics. Schrodinger is the most ...

Both press releases are available on our website at schrodinger.com. Here with me on our call today are Ramy Farid, Chief Executive Officer, Karen Akinsanya, President of R&D Therapeutics ...

Schrödinger shares rise as they announce a research partnership and licensing agreement with Novartis AG. Schrödinger will receive $150 million upfront and eligible to receive up to ...

There’s a common trope in movies and TV where, to show a character is off-the-charts smart, the writers will have them solve ...